Publications of Institute of Radiopharmaceutical Cancer Research - Year 2022
13 Publications2022
Imaging of Gαq proteins in mouse and human organs and tissues
Voss, J. H.; Al-Hroub, H.; Gedschold, R.; Dietrich, J.; Gaffal, E.; et al. (13 authors)
-
Pharmaceutics 15(2023)1, 57
Online First (2022) DOI: 10.3390/pharmaceutics15010057
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents
Keuler, T.; Lemke, C.; Elsinghorst, P. W.; Iriepa, I.; Chioua, M.; et al. (14 authors)
-
ACS Pharmacology & Translational Science 5(2022)11, 1097-1108
DOI: 10.1021/acsptsci.2c00097
Radiosynthesis and preclinical evaluation of an 18F-labeled tri-azolopyridopyrazine-based inhibitor for neuroimaging of the phosphodiesterase 2A (PDE2A)
Wenzel, B.; Fritzsche, S. R.; Toussaint, M.; Briel, D.; Kopka, K.; et al. (8 authors)
-
Pharmaceuticals 15(2022)10, 1272
DOI: 10.3390/ph15101272
PET Imaging of Cholinergic Neurotransmission in Neurodegenerative Disorders
Tiepolt, S.; Meyer, P. M.; Patt, M.; Deuther-Conrad, W.; Hesse, S.; et al. (7 authors)
-
Journal of Nuclear Medicine 63(2022), 33S-44S
DOI: 10.2967/jnumed.121.263198
Novel radioiodinated and radiofluorinated analogues of FT-2102 for SPECT or PET imaging of mIDH1 mutant tumours
Weber, V.; Arnaud, L.; Dukic-Stefanovic, S.; Wenzel, B.; Roux, V.; et al. (12 authors)
-
Molecules 27(2022)12, 3766
DOI: 10.3390/molecules27123766
Synthesis and characterization of the two enantiomers of a chiral sigma-1 receptor radioligand: (S)-(+)- and (R)-(-)-[18F]FBFP
Wang, T.; Zhang, Y.; Zhang, X.; Chen, L.; Zheng, M.-Q.; et al. (10 authors)
-
Chinese Chemical Letters 33(2022)7, 3543-3548
DOI: 10.1016/j.cclet.2022.03.099
Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
Mitrach, F.; Schmid, M.; Toussaint, M.; Dukic-Stefanovic, S.; Deuther-Conrad, W.; et al. (12 authors)
-
Pharmaceutics 14(2022)2, 326
DOI: 10.3390/pharmaceutics14020326
Highlight selection of radiochemistry and radiopharmacy developments by editorial board
Bernardes, E.; Caravan, P.; van Dam, M.; Deuther-Conrad, W.; Ellis, B.; et al. (23 authors)
-
EJNMMI Radiopharmacy and Chemistry 7(2022)1, 9
DOI: 10.1186/s41181-022-00162-3
Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [¹⁸F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain
Clauß, O.; Schäker-Hübner, L.; Wenzel, B.; Toussaint, M.; Deuther-Conrad, W.; et al. (13 authors)
-
Pharmaceuticals 15(2022)3, 324
DOI: 10.3390/ph15030324
Structure-Based Design, Optimization and Development of [18F]LU13, a novel radioligand for CB2R Imaging in the Brain with PET
Gündel, D.; Deuther-Conrad, W.; Ueberham, L.; Kaur, S.; Otikova, E.; et al. (14 authors)
-
Journal of Medicinal Chemistry 65(2022)13, 9034-9049
DOI: 10.1021/acs.jmedchem.2c00256
Automated radiosynthesis of the adenosine A2A receptor-targeting radiotracer [18F]FLUDA
Lai, T. H.; Wenzel, B.; Moldovan, R.-P.; Brust, P.; Kopka, K.; et al. (6 authors)
-
Journal of Labelled Compounds and Radiopharmaceuticals 65(2022), 162-166
DOI: 10.1002/jlcr.3970
Quantitation of the A2A adenosine receptor density in the striatum of mice and pigs with [18F]FLUDA by positron emission tomography
Gündel, D.; Toussaint, M.; Lai, T. H.; Deuther-Conrad, W.; Cumming, P.; et al. (10 authors)
-
Pharmaceuticals 15(2022), 516
DOI: 10.3390/ph15050516
Non-invasive assessment of locally overexpressed human adenosine 2A receptors in the heart of transgenic mice
Gündel, D.; Lai, T. H.; Dukic-Stefanovic, S.; Teodoro, R.; Deuther-Conrad, W.; et al. (13 authors)
-
International Journal of Molecular Sciences 23(2022)3, 1025
DOI: 10.3390/ijms23031025
Years: 2024 2023 2022 2021 2020 2019 2018
